Nordic Cold Chain Launches Tailored Packaging for GLP-1 Drugs

Nordic Cold Chain Solutions has launched a cold chain packaging solution tailored for transporting glucagon-like peptide-1 (GLP-1) medications. The Nordic Express Pack provides consistent temperature regulation, minimises storage requirements, and enhances efficiency for both incoming and outgoing freight. The solution has undergone testing in International Safe Transit Association-certified laboratories, demonstrating its performance in extreme seasonal conditions.

Nordic Cold Chain Solutions has launched a specialized cold chain packaging solution designed to transport glucagon-like peptide-1 (GLP-1) medications. The Nordic Express Pack aims to ensure consistent temperature regulation throughout the shipping process, which is crucial for the therapeutic efficacy of GLP-1 drugs [1].

The solution features a compact, space-efficient design that minimizes storage requirements, allowing for swift operational expansion as demand rises. This packaging enhances efficiency for both incoming and outgoing freight, potentially reducing shipping costs while maintaining stringent quality standards. Incorporated temperature indicators provide visual confirmation of any temperature deviations through color changes, ensuring the integrity of the medications during transit [1].

The Nordic Express Pack has undergone rigorous testing in International Safe Transit Association-certified laboratories, demonstrating its performance in extreme seasonal conditions. This ensures that the packaging can handle the varied temperatures and conditions encountered during global shipping [1].

Keith Baechle, CCO of Nordic Cold Chain Solutions, stated, "Nordic has always been built on a customer-first foundation, focused on truly understanding our partners’ needs and the demands of the marketplace. We built the Nordic Express Pack to solve the real-world challenges of GLP-1 shipping. While there are plenty of generic cold chain mailers available, none have been specifically designed and tested for shipping GLP-1 therapies. With this launch, we’re delivering a faster-to-pack, easier-to-store solution that protects these critical medications without driving up costs" [1].

This launch is part of Nordic Cold Chain Solutions' ongoing commitment to innovation and sustainability. In October 2024, the company successfully acquired Minus Works, a US-based manufacturing company focused on developing sustainable cold chain packaging and shipping products [1].

References:
[1] https://www.packaging-gateway.com/news/nordic-cold-chain-launches-glp-1-drugs/